Role Of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors In The Modulation Of QTc Interval And Ventricular Arrhythmia In Patients With Diabetes Mellitus Combined With Hypertension And Coronary Artery Disease

SGLT2 inhibitors effectively shorten QTc interval, reduce ventricular arrhythmia and cardiovascular risks in DM-HTN-CAD patients and show favorable safety for clinical reference.

Publication Details

Journal
Pakistan Journal of Pharmaceutical Sciences
Published
2026-03-21
DOI
https://doi.org/10.36721/pjps.2026.39.5.reg.15600.1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Role Of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors In The Modulation Of QTc Interval And Ventricular Arrhythmia In Patients With Diabetes Mellitus Combined With Hypertension And Coronary Artery Disease

Pakistan Journal of Pharmaceutical Sciences
Diabetes Treatment and Management
article

Role Of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors In The Modulation Of QTc Interval And Ventricular Arrhythmia In Patients With Diabetes Mellitus Combined With Hypertension And Coronary Artery Disease

article en

Abstract

SGLT2 inhibitors effectively shorten QTc interval, reduce ventricular arrhythmia and cardiovascular risks in DM-HTN-CAD patients and show favorable safety for clinical reference.

Pakistan Journal of Pharmaceutical SciencesVol. 39(5)
Openalex Percentile: Top 11%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Role Of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors In The Modulation Of QTc Interval And Ventricular Arrhythmia In Patients With Diabetes Mellitus Combined With Hypertension And Coronary Artery Disease · Pakistan Journal of Pharmaceutical Sciences (2026) | TGRS Research Map | TGRS